Latest filing published 21 Mar 2014 for Bioxytran, INC, €138.
Insider track record
No signal scores available.
Paul W. Hait: trading record in brief
All filings by Paul W. Hait on record concern Bioxytran, Inc. We count 3 filings; the first trade dates from 15 November 2013 and the latest from 17 March 2014.
Sales make up the whole of the open-market record (3 sales, €6,790). So far in 2014, the count stands at no purchases and 2 sales.
The latest filing, published on 21 March 2014, reports an open-market sale of €138 in Bioxytran, Inc. Filings reach the SEC (Form 4) feed a median of 7 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Paul W. Hait
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,775 shares@ US$0.04Common StockSEC:0001078782-14-000430:0
- 95,225 shares@ US$0.04Common StockSEC:0001078782-14-000430:1
- 54,953 shares@ US$0.0958U.S. Rare Earth Minerals Common StockSEC:0001078782-13-002351:0
3 of 3 declarations